Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Biomedical Engineering,Biomaterials,Medicine (miscellaneous)
Reference19 articles.
1. Ito T, Hanafusa N. CART: Cell-free and concentrated ascites reinfusion therapy against malignancy-related ascites. Transfus Apher Sci. 2017;56:703–7.
2. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117:215–20.
3. Common Terminology Criteria for Adverse Events (CTCAE v5.0). Available at : https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf; Accessed September 23 2022.
4. Scales WE, Vander AJ, Brown MB, Kluger MJ. Human circadian rhythms in temperature, trace metals, and blood variables. J Appl Physiol. 1985;1988:1840–6.
5. Abe T, Matsuo H, Abe R, Abe S, Asada H, Ashida A, Baba A, Eguchi K, Eguchi Y, Endo Y, Fujimori Y. The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis. Ther Apher Dial. 2021;25:728–876.